[1] Nilsen TW, Graveley BR.Expansion of the eukaryotic proteome by alternative splicing[J]. Nature, 2010, 463(7280): 457-463. [2] Wang Q, Zhou T.Alternative-splicing-mediated gene expression[J]. Phys Rev E Stat Nonlin Soft Matter Phys, 2014, 89(1): 012713. [3] Luhrmann R, Kastner B, Bach M.Structure of spliceosomal snRNPs and their role in pre-mRNA splicing[J]. Biochim Biophys Acta, 1990, 1087(3): 265-292. [4] Will CL, Lührmann R.Spliceosome structure and function[J]. Cold Spring Harb Perspect Biol, 2011, 3(7): a003707. [5] Andersen J, Zieve GW.Assembly and intracellular transport of snRNP particles[J]. Bioessays, 1991, 13(2): 57-64. [6] Guthrie C, Patterson B.Spliceosomal snRNAs[J]. Annu Rev Genet, 1988, 22: 387-419. [7] Jobert L, Pinzon N, Van Herreweghe E, et al.Human U1 snRNA forms a new chromatin-associated snRNP with TAF15[J]. EMBO Rep, 2009, 10(5): 494-500. [8] Leichter M, Marko M, Ganou V, et al.A fraction of the transcription factor TAF15 participates in interactions with a subset of the spliceosomal U1 snRNP complex[J]. Biochim Biophys Acta, 2011, 1814(12): 1812-1824. [9] Kwek KY, Murphy S, Furger A, et al.U1 snRNA associates with TFIIH and regulates transcriptional initiation[J]. Nat Struct Biol, 2002, 9(11): 800-805. [10] Ran Y, Deng Y, Yao C.U1 snRNP telescripting: molecular mechanisms and beyond[J]. RNA Biol, 2021, 18(11): 1512-1523. [11] Di C, So BR, Cai Z, et al.U1 snRNP Telescripting Roles in Transcription and Its Mechanism[J]. Cold Spring Harb Symp Quant Biol, 2019, 84: 115-122. [12] Furth PA, Baker CC.An element in the bovine papillomavirus late 3′ untranslated region reduces polyadenylated cytoplasmic RNA levels[J]. J Virol, 1991, 65(11): 5806-5812. [13] Spraggon L, Cartegni L.U1 snRNP-Dependent Suppression of Polyadenylation: Physiological Role and Therapeutic Opportunities in Cancer[J]. Int J Cell Biol, 2013, 2013: 846510. [14] Yin Y, Lu JY, Zhang X, et al.U1 snRNP regulates chromatin retention of noncoding RNAs[J]. Nature, 2020, 580(7801): 147-150. [15] Nino CA, Scotto di Perrotolo R, Polo S. Recurrent Spliceosome Mutations in Cancer: Mechanisms and Consequences of Aberrant Splice Site Selection[J]. Cancers (Basel), 2022, 14(2). [16] Oh JM, Venters CC, Di C, et al.U1 snRNP regulates cancer cell migration and invasion in vitro[J]. Nat Commun, 2020, 11(1): 1. [17] Li S, Zhang S, Huang M, et al.U1RNP/lncRNA/Transcription Cycle Axis Promotes Tumorigenesis of Hepatocellular Carcinoma[J]. Diagnostics (Basel), 2022, 12(5): 1133. [18] Cheng Z, Sun Y, Niu X, et al.Gene expression profiling reveals U1 snRNA regulates cancer gene expression[J]. Oncotarget, 2017, 8(68): 112867-112874. [19] Hsu TY, Simon LM, Neill NJ, et al.The spliceosome is a therapeutic vulnerability in MYC-driven cancer[J]. Nature, 2015, 525(7569): 384-388. [20] Chu C, Chang HY.ChIRP-MS: RNA-Directed Proteomic Discovery[J]. Methods Mol Biol, 2018, 1861: 37-45. [21] Lee J, Nguyen PT, Shim HS, et al.EWSR1, a multifunctional protein, regulates cellular function and aging via genetic and epigenetic pathways[J]. Biochim Biophys Acta Mol Basis Dis, 2019, 1865(7): 1938-1945. [22] Ehrmann I, Dalgliesh C, Tsaousi A, et al.Haploinsufficiency of the germ cell-specific nuclear RNA binding protein hnRNP G-T prevents functional spermatogenesis in the mouse[J]. Hum Mol Genet, 2008, 17(18): 2803-2818. [23] Guerrier-Takada C, Gardiner K, Marsh T, et al.The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme[J]. Cell, 1983, 35(3 Pt 2): 849-857. [24] Moore PB, Steitz TA.The involvement of RNA in ribosome function[J]. Nature, 2002, 418(6894): 229-235. [25] Sloan KE, Warda AS, Sharma S, et al.Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function[J]. RNA Biol, 2017, 14(9): 1138-1152. [26] Corley M, Burns MC, Yeo GW.How RNA-Binding Proteins Interact with RNA: Molecules and Mechanisms[J]. Mol Cell, 2020, 78(1): 9-29. [27] Hentze MW, Castello A, Schwarzl T, Preiss T.A brave new world of RNA-binding proteins[J]. Nat Rev Mol Cell Biol, 2018, 19(5): 327-341. [28] Guo C, Liu S, Wang J, et al.ACTB in cancer[J]. Clin Chim Acta, 2013, 417: 39-44. [29] Notari M, Neviani P, Santhanam R, et al.A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation[J]. Blood, 2006, 107(6): 2507-2516. [30] Yan Q, Zeng P, Zhou X, et al.RBMX suppresses tumorigenicity and progression of bladder cancer by interacting with the hnRNP A1 protein to regulate PKM alternative splicing[J]. Oncogene, 2021, 40(15): 2635-2650. [31] Prieto C, Nguyen DTT, Liu Z, et al.Transcriptional control of CBX5 by the RNA binding proteins RBMX and RBMXL1 maintains chromatin state in myeloid leukemia[J]. Nat Cancer, 2021, 2: 741-757. [32] Zhou HZ, Li F, Cheng ST, et al.DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis[J]. Hepatology, 2022, 75(4): 847-865. [33] Liu X, Li L, Geng C, et al.DDX17 promotes the growth and metastasis of lung adenocarcinoma[J]. Cell Death Discov, 2022, 8(1): 425. [34] Bhan A, Soleimani M, Mandal SS.Long Noncoding RNA and Cancer: A New Paradigm[J]. Cancer Res, 2017, 77(15): 3965-3981. [35] Chen L, Shan G.CircRNA in cancer: Fundamental mechanism and clinical potential[J]. Cancer Lett, 2021, 505: 49-57. [36] Lu J, Getz G, Miska EA, et al.MicroRNA expression profiles classify human cancers[J]. Nature, 2005, 435(7043): 834-838. [37] Kousar K, Ahmad T, Abduh MS, et al.miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer[J]. Int J Mol Sci, 2022, 23(22):13822. [38] Patel SB, Novikova N, Bellini M.Splicing-independent recruitment of spliceosomal small nuclear RNPs to nascent RNA polymerase II transcripts[J]. J Cell Biol, 2007, 178(6): 937-949. |